Electromed, Inc. to Participate in Two Upcoming Investor Conferences

NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that management is scheduled to participate in two upcoming investor conference during the month of November 2022:

• Sidoti & Company November Micro-Cap Virtual Conference on November 9-10, 2022.
• Three Part Advisors 14th Annual Southwest IDEAS Conference on November 16-17, 2022

About Sidoti & Company November Micro-Cap Virtual Conference

Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, will present on Wednesday, November 9, 2022 at 3:15 – 3:45 pm Eastern Time, and participate in investor 1x1s. A link to the live webcast of the presentation is available here. A replay of available webcasts will be accessible for 90 days following the live event.

About Three Part Advisors 14th Annual Southwest IDEAS Conference

Kathleen Skarvan, Michelle Wirtz, and Brad Nagel, the recently appointed Chief Financial Officer, will present on Wednesday, November 16, 2022 at 9:45 – 10:20 am Eastern Time / 8:45 – 9:20 am Central Time, and participate in investor 1x1s. A link to a replay of the event will be available 15 minutes after the conclusion of the presentation, here.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about the Company can be found at www.smartvest.com.

Source: Electromed, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221103005260/en/

Michelle Wirtz, Interim Chief Financial Officer
(952) 758-9299
[email protected]

Mike Cavanaugh, Investor Relations
ICR Westwicke
(617) 877-9641
[email protected]

Source: Electromed, Inc.

You May Also Be Interested In

• KBRA Assigns Preliminary Ratings to FMC GMSR Issuer Trust, Series 2026-GT1 (FMC GMSR 2026-GT1)
• Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results
• Dan Simkowitz to Speak at the Barclays Global Financial Services Conference